Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase.
Get this sample report, completely free
DOWNLOAD NOW
In case you want this report emailed straight into your email inbox, kindly share your details below. Please note that you agree to receive email updates from us on our new reports and solutions.
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
The Summary report contains the SWOT & PESTLE table contents only. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this free summary report
DOWNLOAD REPORT
In case you want this report emailed straight into your email inbox, kindly share your details below. Please note that you agree to receive email updates from us on our new reports and solutions.

GlaxoSmithKline SWOT and PESTLE Analysis

ID : 52166353| Aug 2023

COMPANY PROFILE -GlaxoSmithKline Plc

Business Sector :Pharmaceuticals and Consumer Healthcare

Operating Geography :United Kingdom, Global

About GlaxoSmithKline Plc :

GSK is a global biopharmaceutical company with its headquarters located in London, United Kingdom. As of 2023, the company boasts an extensive and dedicated workforce of 69,400 spread across various countries, working towards a common purpose of advancing healthcare and making a transformative impact on patient's lives. With a rich history of pioneering medical breakthroughs and delivering innovative healthcare solutions, GSK has been at the forefront of addressing unmet medical needs for decades. The company's core business revolves around discovering, developing, and manufacturing vaccines, medicines, and consumer healthcare products. Its diversified portfolio covers a wide range of therapeutic areas, including infectious diseases, oncology, respiratory, immunology, and more. On May 16, 2022, the company underwent a name change from GlaxoSmithKline to GSK.

With 37 manufacturing sites and a vast network of over 24,000 suppliers, GSK ensures the efficient production and supply of its products to meet the healthcare demands of patients across the globe. The company's vaccines division is a global leader, delivering millions of vaccine doses every day. Approximately 40% of the world's children receive a GSK vaccine annually. GSK has been ranked 1st in the Access to Medicine Index and achieved a remarkable 2nd position in the pharmaceuticals industry according to the S&P Global Corporate Sustainability Assessment with a score of 86 as of 17th February 2023. These achievements further solidify GSK's position as a key player in the pharmaceutical industry, committed to making a positive impact on society and the environment.

As a leading biopharmaceutical company, GSK's unique selling proposition lies in its robust research and development capabilities, which have led to numerous groundbreaking discoveries and innovative treatments. Guided by its vision to unite science, technology, and talent, GSK's mission is to positively impact the health of 2.5 billion people by the end of 2030. With this mission in mind, GSK strives to deliver life-changing treatments and preventive solutions to patients worldwide.

GlaxoSmithKline Plc Revenue :


£ 29.3 billion - FY ending 31st Dec 2022 (y-o-y growth -14.08%)
£ 34.1 billion - FY ending 31st Dec 2021

Competitive Analysis of GlaxoSmithKline Plc

SWOT
PESTLE
The SWOT analysis for GSK is presented below in a matrix format followed by a detailed analysis:
Strengths
Weaknesses
1. Global sales and marketing infrastructure
2. Strategic collaborations and acquisitions driving innovation and growth in healthcare:
3. Strong financial performance and strategic initiatives:
4. Advancing healthcare through research and development innovation and collaboration:
5. Strengthening the manufacturing network to support growth in vaccines and specialty medicines
1. GSK’s brand image is affected by the health care settlements in the US and bribery charges:
Opportunities
Threats
1. Growth opportunity in the vaccines business
2. Growth opportunity in the HIV and infectious disease business
3. Opportunities in the emerging markets driven by the increasing awareness about healthcare needs
4. UK grants groundbreaking authorization for RSV Vaccine
5. Opportunity in the growing nicotine gum market:
1. Intense competition from Generic drugs
2. Drug pricing controls leading to cost containment pressures
3. Challenges to patent protection by competitors:
SWOT & PESTLE (combined)
Complete Report
USD 12.53
*
  • Debit/Credit card
  • PayPal
Great quality, Affordable pricing.
Safe and secure payments
On purchase the GlaxoSmithKline SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.

Detailed SWOT Analysis of GlaxoSmithKline Plc

Strength

1. Global sales and marketing infrastructure: GlaxoSmithKline (GSK) has a global presence with 37 manufacturing sites and a vast network of over 24,000 suppliers, ensuring the efficient production and supply of its products. The company's General Medicines portfolio consists of more than 150 primary care medicines, distributed in 112 countries worldwide. GSK's dedicated workforce of 69,400 employees plays a pivotal role in driving innovation and delivering essential healthcare solutions to patients in over 80 countries across the globe. The global biopharma company, driven by its purpose to unite science, technology, and talent to combat disease together, has set ambitious goals to positively impact the health of 2.5 billion people by 2030. Their commitment to growth and significant performance improvement reflects their bold ambitions to better the lives of patients worldwide.

2. Strategic collaborations and acquisitions driving innovation and growth in healthcare: GSK's strategic collaborations and acquisitions present the opportunity to bolster their pipeline and address unmet medical needs. The acquisition of Bellus Health offers access to camlipixant, potentially leading to significant sales in treating refractory chronic cough. Collaborations with Tempus, Mersana Therapeutics, WuXi, Zheming, and Wave Life Sciences provide access to new vaccines, medicines, and technologies for disease prevention and treatment. In 2022, GSK completed the acquisitions of Sierra Oncology, a targeted therapies-focused biopharmaceutical company, and Affinivax, a clinical-stage biopharmaceutical company with a next-generation pneumococcal vaccine candidate and innovative MAPS technology, aiming to strengthen its pipeline and address unmet medical needs. These endeavors demonstrate GSK's commitment to business development and growth, enabling them to further advance their expertise in respiratory medicines and expand their research capabilities in pursuit of innovative healthcare solutions.

The remaining section under "Strength" is available only in the 'Complete Report' on purchase.

Weakness

This section is available only in the 'Complete Report' on purchase.

Opportunity

This section is available only in the 'Complete Report' on purchase.

Threat

This section is available only in the 'Complete Report' on purchase.

Major Brands :

    Pharmaceutical products
  • Calpol, others
    Vaccine
  • Havrix (for hepatitis A)
  • Rotarix (for human rotavirus)
  • Typherix (for typhoid)
    Consumer healthcare products
  • Aquafresh
  • Binaca
  • Horlicks
  • Nicorette
  • Panadol
  • Sensodyne
SWOT & PESTLE (combined)
Complete Report
USD 12.53
*
  • Debit/Credit card
  • PayPal
Great quality, Affordable pricing.
Safe and secure payments
On purchase the GlaxoSmithKline SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
WHY BUY THIS REPORT?
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
• The SWOT and PESTEL analysis report of GLAXOSMITHKLINE manifests the complex internal and external factors affecting the GSK's brand, its operations, business model, market strategy and growth trajectory.
• The SWOT analysis assesses the strengths and opportunities that GSK possesses and how it strategizes itself to overcome its weaknesses and threats in its operating macro environment.
• Understanding the role of technology and the company's core competencies in shaping GSK's business and presenting the company with a competitive advantage over its competitors.
• The PESTLE analysis of the Pharmaceutical and Healthcare Industry helps to distinguish the factors that compel and restrain the entire industry and largely GSK.
• The PESTLE/ PESTEL/ STEEPL Analysis provides in-depth analysis of all external factors specifically, political, economic, social, technological, legal and environmental, highlighting their consequence on GSK's business model, marketing and growth strategy.
• Abstract information on GSK's business diversification, deriving its key business segments and highlighting its major competitors.
• A comprehensive company analysis to obtain perspicacity into company information, company profile, business model, business plans and marketing strategy.
• Analysis of GSK's mergers and acquisitions, strategic partnerships and alliances, that the GSK endorsed, and the business aims or synergies that were achieved with them.
• Interpretation of GSK’s USP or unique selling proposition, mission statement, and vision statement. With a peek into the GSK's key performance indicators, core values, success factors, value proposition, and core competencies.
• Discussion on H&M's business model, extending to the analysis of key business segments and business case study.

You may also be interested in other analyses of GlaxoSmithKline Plc:

Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
GlaxoSmithKline Plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.

Check Out Analysis of Other Relevant Companies

References used in GlaxoSmithKline Plc SWOT & PESTLE Analysis Report

1. GSK's Annual Report for 2022: https://www.gsk.com/media/9956/annual-report-2022.pdf
2. GSK and May & Baker Show Strong Cash Flows in First Quarter Results: https://businessday.ng/companies/article/gsk-may-baker-show-strong-cash-flows-in-first-quarter-results/
3. GSK Acquires Biopharmaceutical Company Bellus Health: https://www.thechemicalengineer.com/news/gsk-acquires-biopharmaceutical-company-bellus-health/
4. SK's Viiv Explores Novel Pathway for Long-Acting HIV Drug Cabenuva in Tough Populations: https://www.fiercepharma.com/pharma/gsks-viiv-explores-novel-pathway-bring-long-acting-hiv-drug-cabenuva-tough-populations
The detailed complete set of references are available on request in the 'Complete report' on purchase.

How to Reference This Page?

You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.

GlaxoSmithKline SWOT and PESTLE Analysis - SWOT & PESTLE.COM

SWOT & PESTLE.com (2024). GlaxoSmithKline SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/glaxosmithkline/ [Accessed 19 Apr, 2024].

In-text: (SWOT & PESTLE.com, 2024)

Copyrights and Disclaimer

GlaxoSmithKline SWOT analysis has been conducted by Mahakpreet Singh Bhatia and reviewed by senior analysts from Barakaat Consulting.

Copyright of GlaxoSmithKline (GSK) SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions page for usage guidelines.
GlaxoSmithKline SWOT and PESTLE Analysis
Price : USD 12.53
Open chat
1
Hello
How can I Help You?